232
Participants
Start Date
January 31, 2007
Primary Completion Date
November 30, 2008
Study Completion Date
May 31, 2009
Placebo
PO BID
LX211
0.2 mg/kg, twice a day (BID)
LX211
0.4 mg/kg, twice a day (BID)
LX211
0.6 mg/kg, twice a day (BID)
New York Eye & Ear Hospital, New York
Viginia Eye Consultants, Norfolk
Midwest Eye Institute, Indianapolis
Associated Retinal Consultants, PC, Grand Rapids
University of Illinois - Chicago, Chicago
Tauber Eye Center, Kansas City
Texas Retina Associates, Dallas
Texas Retina Associates, Arlington
Vitreoretinal Consultants, Houston
Retina & Uveitis Consultants of Texas, San Antonio
Brian B. Berger, MD, P.A., Austin
Retinal Consultants of Arizona, Phoenix
Oregon Health Sciences University, Portland
University of Alabama at Birmingham, Birmingham
Wilmer Eye Institute, Baltimore
Massachusetts Eye and Ear Infirmary, Boston
Duke University Eye Center, Erwin Road, Durham
Universitätsklinik für Augenheilkunde, Salzburg
Klinik für Augenheilkunde, Dept. of Ophthalmology, Vienna
Center Hospitalier Universitaire d' Angers, Service d'Opthalmologie, Angers
Hôpital Pitié Salpétrière, Service d'Ophtalmologie, Paris
Universitätsklinikum Freiburg, Freiburg im Breisgau
Augenklinik der Universität Heidelberg, Heidelberg
Universitätsklinikum Tübingen, Tübingen
L V Prasad Eye Institute, Hyderabaad
Consultant, Retina and Vitreous Services, Bhubaneswar L V Prasad Eye Institute, Bhubaneswar
Department of Opthalmology, Sankara Nethralaya, Medical Research Foundation,, Chennai
Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai
Vittala International Institute of Ophthalmology, Bangalore
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh
Aravind Eye Hospital, Uvea Clinic, Coimbatore
Aditya Jyot Eye Hospital Pvt Ltd, Mumbai
Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi
Bristol Eye Hospital and University of Bristol, Bristol
Royal Liverpool University Hospital, Liverpool
Moorfields Eye Hospital, London
Massachusetts Eye Research and Surgery Institute, Cambridge
UMDNJ-New Jersey Medical School, Ophthalmology Dept., Newark
Ivey Eye Institute, London
University of Ottawa Eye Institute, Ottawa
McGill University Health Center, Montreal
Lead Sponsor
Lux Biosciences, Inc.
INDUSTRY